MA31364B1 - Sulfamides substitués, leur procédé de préparation, composition pharmaceutique en contenant et leur utilisation - Google Patents

Sulfamides substitués, leur procédé de préparation, composition pharmaceutique en contenant et leur utilisation

Info

Publication number
MA31364B1
MA31364B1 MA32329A MA32329A MA31364B1 MA 31364 B1 MA31364 B1 MA 31364B1 MA 32329 A MA32329 A MA 32329A MA 32329 A MA32329 A MA 32329A MA 31364 B1 MA31364 B1 MA 31364B1
Authority
MA
Morocco
Prior art keywords
preparation process
pharmacological composition
aliphatic chain
activity
substituted sulfamide
Prior art date
Application number
MA32329A
Other languages
Arabic (ar)
English (en)
Inventor
Jarmila Knapikova
Fridrich Gregan
Milan Remko
Elena Sluciakova
Original Assignee
Unimed Pharma Spol Sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimed Pharma Spol Sro filed Critical Unimed Pharma Spol Sro
Publication of MA31364B1 publication Critical patent/MA31364B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne des sulfamides substitués de formule générale (i) et leurs sels, hydrates et solvates, où r1 représente co ou so2 et r2 nh ou o et où r représente une chaîne aliphatique linéaire ou cyclique et n le nombre d'atomes de carbone de liaison de la chaîne aliphatique (n pouvant être égal à 0, 1, 2 ou 3), utilisables dans la fabrication de médicaments du fait de leur activité en matière d'inhibition de la carboanhydrase. Ces composés sont préparés par une réaction nucléophile entre une amine et du chlorure de sulfamoylbenzènesulfonyle en présence d'un excès de triéthylamine dans du tétrahydrofurane ou de l'éther à une température de 0 à 20 °c. Ces composés présentent une activité anti-glaucome.
MA32329A 2007-04-20 2009-11-05 Sulfamides substitués, leur procédé de préparation, composition pharmaceutique en contenant et leur utilisation MA31364B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SK54-2007A SK542007A3 (sk) 2007-04-20 2007-04-20 Substituované sulfónamidy, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
PCT/SK2008/050005 WO2008130332A1 (fr) 2007-04-20 2008-04-18 Sulfamides substitués, leur procédé de préparation, composition pharmaceutique en contenant et leur utilisation

Publications (1)

Publication Number Publication Date
MA31364B1 true MA31364B1 (fr) 2010-05-03

Family

ID=39671772

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32329A MA31364B1 (fr) 2007-04-20 2009-11-05 Sulfamides substitués, leur procédé de préparation, composition pharmaceutique en contenant et leur utilisation

Country Status (31)

Country Link
US (1) US8193184B2 (fr)
EP (1) EP2142499B1 (fr)
JP (1) JP5492764B2 (fr)
CN (1) CN101663267A (fr)
AR (1) AR065966A1 (fr)
AU (1) AU2008241590B2 (fr)
BR (1) BRPI0809728A2 (fr)
CA (1) CA2684591C (fr)
CL (1) CL2008001109A1 (fr)
DK (1) DK2142499T3 (fr)
ES (1) ES2528284T3 (fr)
HR (1) HRP20141246T1 (fr)
HU (1) HUE024552T2 (fr)
IL (1) IL200952A0 (fr)
JO (1) JO3206B1 (fr)
MA (1) MA31364B1 (fr)
MX (1) MX2009010528A (fr)
NZ (1) NZ581302A (fr)
PE (1) PE20090807A1 (fr)
PL (1) PL2142499T3 (fr)
PT (1) PT2142499E (fr)
RU (1) RU2474574C2 (fr)
SA (1) SA08290238B1 (fr)
SI (1) SI2142499T1 (fr)
SK (1) SK542007A3 (fr)
TN (1) TN2009000421A1 (fr)
TW (1) TWI392492B (fr)
UA (1) UA99279C2 (fr)
UY (1) UY31028A1 (fr)
WO (1) WO2008130332A1 (fr)
ZA (1) ZA200906305B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115141128B (zh) * 2022-06-24 2024-09-13 沈阳药科大学 3-芳基-3-(磺胺苯甲酰胺基)丙(烯)酸衍生物及其制备方法及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789938A (en) * 1952-11-24 1957-04-23 Merck & Co Inc Method of producing a diuretic effect with p-carboxybenzenesulfonamide
CH451142A (de) * 1965-01-19 1968-05-15 Sandoz Ag Verfahren zur Herstellung neuer basisch substituierter Benzoesäureamide
GB1523631A (en) * 1975-07-08 1978-09-06 Leo Pharm Prod Ltd Sulphonamide derivatives
EP0029090A3 (fr) * 1979-09-28 1981-07-01 American Cyanamid Company Sulfonamides contenant un phénol stériquement empêché; composition stabilisée à base d'un polymère synthétique et des sulfonamides mentionnés
FR2504528A1 (fr) * 1981-04-23 1982-10-29 Choay Sa Dialcoxy (2,4) benzenesulfonamides n-substitues
JPS5939867A (ja) * 1982-08-27 1984-03-05 Fuji Yakuhin Kogyo Kk ２−クロロスルホニル−４−ｎ−置換スルフアミル−クロロベンゼンの製造法
JPS6041071B2 (ja) * 1983-07-28 1985-09-13 ソシエテ・デチユ−デ・シヤンテイフイツク・エ・アンデユストリエル・ドウ・リル−ドウ−フランス 安息香酸誘導体
US4678855A (en) * 1985-10-09 1987-07-07 Merck & Co., Inc. Substituted benzenesulfonamides
US4721809A (en) * 1986-09-18 1988-01-26 American Home Products Corporation Alkylsulfonamido or perfluoroalkylsulfonamido benzenesulfonamides
WO1995024186A1 (fr) * 1994-03-11 1995-09-14 Pharmacopeia, Inc. Derives de sulfonamide et leurs utilisations
JP2001162950A (ja) * 1999-12-13 2001-06-19 Fuji Photo Film Co Ltd 感熱記録材料
JP4139712B2 (ja) * 2002-03-14 2008-08-27 ライオン株式会社 漂白活性化剤及び漂白剤組成物
EP3470108A1 (fr) * 2004-07-02 2019-04-17 Mati Therapeutics Inc. Dispositif de mise en place d'un moyen de traitement destinees a la mise en place dans l'oeil
SE0401969D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Piperidine derivatives
WO2008071421A1 (fr) * 2006-12-15 2008-06-19 Nicox S.A. Esters de l'acide nitrique des inhibiteurs d'anhydrase carbonique

Also Published As

Publication number Publication date
CN101663267A (zh) 2010-03-03
NZ581302A (en) 2012-03-30
RU2474574C2 (ru) 2013-02-10
RU2009134079A (ru) 2011-05-27
AR065966A1 (es) 2009-07-15
AU2008241590B2 (en) 2012-06-21
PE20090807A1 (es) 2009-07-20
ZA200906305B (en) 2010-05-26
TN2009000421A1 (en) 2011-03-31
SA08290238B1 (ar) 2012-06-23
PT2142499E (pt) 2015-02-09
CL2008001109A1 (es) 2008-11-03
SI2142499T1 (sl) 2015-04-30
UY31028A1 (es) 2008-11-28
TW200843730A (en) 2008-11-16
DK2142499T3 (en) 2015-01-12
JO3206B1 (ar) 2018-03-08
IL200952A0 (en) 2010-05-17
HRP20141246T1 (hr) 2015-02-13
WO2008130332A1 (fr) 2008-10-30
AU2008241590A1 (en) 2008-10-30
TWI392492B (zh) 2013-04-11
HUE024552T2 (hu) 2016-02-29
US20100125076A1 (en) 2010-05-20
CA2684591C (fr) 2016-11-01
UA99279C2 (ru) 2012-08-10
JP2010524929A (ja) 2010-07-22
MX2009010528A (es) 2011-01-28
US8193184B2 (en) 2012-06-05
EP2142499B1 (fr) 2014-12-10
SK542007A3 (sk) 2008-11-06
ES2528284T3 (es) 2015-02-06
BRPI0809728A2 (pt) 2016-10-18
JP5492764B2 (ja) 2014-05-14
CA2684591A1 (fr) 2008-10-30
EP2142499A1 (fr) 2010-01-13
WO2008130332B1 (fr) 2008-12-18
PL2142499T3 (pl) 2015-05-29

Similar Documents

Publication Publication Date Title
HUP0203700A2 (hu) N-szubsztituált cianopirrolidinek és cukorbetegség-ellenes szerként való alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények
EA200300531A1 (ru) Производные фталазинона
TW200635585A (en) Monocyclic substituted methanones
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
TW200612920A (en) Novel imidazolidine derivatives
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
EA200601295A1 (ru) Производные 1,3-диоксана и их аналоги, применимые для лечения i.a. ожирения и диабета
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
TR200101478T2 (tr) Organik bileşikler.
MY140528A (en) Spiroketal derivatives and their use as therapeutic agents for diabetes
BRPI0212775B8 (pt) composto de 1,2,4-triazol e medicamento
NO20080157L (no) Fremgangsmate for syntese av organiske forbindelser
IL175940A0 (en) Prostaglandin synthesis
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
MY143665A (en) Method of producing aminophenol compounds.
ATE482933T1 (de) Sulfopyrrolderivate
EA200970555A1 (ru) Трициклическое соединение и его медицинское применение
MA31364B1 (fr) Sulfamides substitués, leur procédé de préparation, composition pharmaceutique en contenant et leur utilisation
DE60210719D1 (de) Verbindung enthaltend einen heterozyklischen Ring sowie eine Schmiermittelmischung enthaltend diese
EA200401077A1 (ru) 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b
UA90290C2 (ru) Производные спирокеталов и их применение в качестве лекарственного средства против диабета
Du et al. Design and synthesis of N-alkyldeoxynojirimycin derivatives with improved metabolic stability as inhibitors of BVDV and Tacaribe virus
MA29534B1 (fr) Agents de couplage de benzenephosphonate organometallique
KR910021401A (ko) 헥사하이드로피롤로[2,3-b]인 돌 카바메이트, -우레아, -아미드 및 관련 화합물, 이의 제조방법 및 약제로서의 이들의 용도
TW200626007A (en) Material for electroluminescent element and electroluminescent element